PhRMA on Monday, April 8, submitted comments on the Department of Health and Human Services Office of Inspector General’s proposed rule for addressing the current rebate system.
The rule, “Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees,” was proposed in March.
“PhRMA supports the policies underlying OIG’s proposed modifications to the safe harbors and our member companies are committed to working with OIG to facilitate implementation by 2020 so that Medicare Part D beneficiaries may see the benefit of these policies,” PhRMA said in its comments. “Rapid implementation of the reforms proposed by OIG will be challenging for manufacturers and other stakeholders, but we consider these changes too important to delay.”
To read more, click here.